According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$22.05 Million. In 2023 the company made an earning of -NZ$46.76 Million, an increase over its 2022 earnings that were of -NZ$66.36 Million. The earnings displayed on this page is the company's Pretax Income.